United States - English - NLM (National Library of Medicine)

micro labs limited - tranexamic acid (unii: 6t84r30kc1) (tranexamic acid - unii:6t84r30kc1) - tranexamic acid 100 mg in 1 ml - tranexamic acid injection is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. tranexamic acid injection is contraindicated: - in patients with subarachnoid hemorrhage. anecdotal experience indicates that cerebral edema and cerebral infarction may be caused by tranexamic acid injection in such patients. - in patients with active intravascular clotting [see warnings and precautions ( 5.1 )] . - in patients with hypersensitivity to tranexamic acid or any of the ingredients [see warnings and precautions ( 5.4 )] . risk summary available data from published studies, case series and case reports with tranexamic acid use in pregnant women in the second and third trimester and at the time of delivery have not clarified whether there is a drug-associated risk of miscarriage or adverse maternal or fetal outcomes. there

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - tranexamic acid 100 mg/ml - tranexamic acid

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - tranexamic acid 100 mg/ml - tranexamic acid

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - tranexamic acid - solution for injection - tranexamic acid 100 mg/ml - antihemorrhagics

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - tranexamic acid - solution for injection - tranexamic acid 100 mg/ml - antihemorrhagics

Australia - English - Department of Health (Therapeutic Goods Administration)

luminarie pty ltd - tranexamic acid, quantity: 100 mg/ml - injection, solution - excipient ingredients: water for injections - adults,for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty.,paediatrics,for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - tranexamic acid - solution for injection/infusion - tranexamic acid 100 mg/ml - antihemorrhagics

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - tranexamic acid - solution for injection/infusion - tranexamic acid 100 mg/ml - antihemorrhagics

New Zealand - English - Medsafe (Medicines Safety Authority)

luminarie group limited - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - active: tranexamic acid 100 mg/ml excipient: water for injection - adults: for the reduction of peri - and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. paediatrics: for the reduction of peri - and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - active: tranexamic acid 100 mg/ml excipient: nitrogen water for injection - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. localfibrinolysis may occur in the following conditions: · prostatectomy and bladder surgery · menorrhagia · epistaxis · conisation of the cervix · management of dental extraction in patients with coagulopathies · ulcerative colitis · haematuria (tranexamic acid therapy is not indicated in haematuria caused by diseases of the renal parenchyma (also see precautions). · gastrointestinal haemorrhage